Back to News & Events

NYC Builds Bio+: 2021 Life Sciences Real Estate Development Symposium

November 4, 2021
8:00 AM – 3:00 PM

REGISTER HERE

The fourth Annual NYC Builds Bio+ Real Estate Development Symposium will focus on the Greater New York Metropolitan area (which also encompasses eastern New Jersey and southern Connecticut), and how it has emerged as the largest and one of the fastest growing life sciences economies in the country.

The Symposium is NYC Builds Bio+’s flagship event and was launched in 2018 as a catalyst for driving targeted life science initiatives in New York City. All proceeds from the Symposium will be dedicated to supporting NYC Builds Bio+, New York’s premier not-for-profit association connecting commercial life science opportunities to the real estate development community.

Creating Specialized Life Science and Lab Space in New York City

A recent NYC City Planning study of the Life Science economy concluded that the NY Metro area, which also encompasses eastern New Jersey and southern Connecticut, enjoys the largest life science economy in the United States. The 2020 Census data indicates that it is also one of the fastest growing markets in the country.

Join the Fourth Annual Life Science Real Estate Development Symposium to hear how private and public investments are driving exponential growth for the life science industry, what new initiatives are furthering innovation in the space and what this means for the Greater NY Metropolitan Area.

Event website: https://www.nycbuildsbio.org/events-test/2021-life-sciences-real-estate-development-symposium/

Related Stories

WP_Query Object
(
    [query] => Array
        (
            [post_type] => post
            [posts_per_page] => 3
            [post_status] => publish
            [orderby] => rand
        )

    [query_vars] => Array
        (
            [post_type] => post
            [posts_per_page] => 3
            [post_status] => publish
            [orderby] => rand
            [error] => 
            [m] => 
            [p] => 0
            [post_parent] => 
            [subpost] => 
            [subpost_id] => 
            [attachment] => 
            [attachment_id] => 0
            [name] => 
            [pagename] => 
            [page_id] => 0
            [second] => 
            [minute] => 
            [hour] => 
            [day] => 0
            [monthnum] => 0
            [year] => 0
            [w] => 0
            [category_name] => 
            [tag] => 
            [cat] => 
            [tag_id] => 
            [author] => 
            [author_name] => 
            [feed] => 
            [tb] => 
            [paged] => 0
            [meta_key] => 
            [meta_value] => 
            [preview] => 
            [s] => 
            [sentence] => 
            [title] => 
            [fields] => all
            [menu_order] => 
            [embed] => 
            [category__in] => Array
                (
                )

            [category__not_in] => Array
                (
                )

            [category__and] => Array
                (
                )

            [post__in] => Array
                (
                )

            [post__not_in] => Array
                (
                )

            [post_name__in] => Array
                (
                )

            [tag__in] => Array
                (
                )

            [tag__not_in] => Array
                (
                )

            [tag__and] => Array
                (
                )

            [tag_slug__in] => Array
                (
                )

            [tag_slug__and] => Array
                (
                )

            [post_parent__in] => Array
                (
                )

            [post_parent__not_in] => Array
                (
                )

            [author__in] => Array
                (
                )

            [author__not_in] => Array
                (
                )

            [search_columns] => Array
                (
                )

            [ignore_sticky_posts] => 
            [suppress_filters] => 
            [cache_results] => 1
            [update_post_term_cache] => 1
            [update_menu_item_cache] => 
            [lazy_load_term_meta] => 1
            [update_post_meta_cache] => 1
            [nopaging] => 
            [comments_per_page] => 50
            [no_found_rows] => 
            [order] => 
        )

    [tax_query] => WP_Tax_Query Object
        (
            [queries] => Array
                (
                )

            [relation] => AND
            [table_aliases:protected] => Array
                (
                )

            [queried_terms] => Array
                (
                )

            [primary_table] => wp_posts
            [primary_id_column] => ID
        )

    [meta_query] => WP_Meta_Query Object
        (
            [queries] => Array
                (
                )

            [relation] => 
            [meta_table] => 
            [meta_id_column] => 
            [primary_table] => 
            [primary_id_column] => 
            [table_aliases:protected] => Array
                (
                )

            [clauses:protected] => Array
                (
                )

            [has_or_relation:protected] => 
        )

    [date_query] => 
    [request] => SELECT SQL_CALC_FOUND_ROWS  wp_posts.ID
					 FROM wp_posts 
					 WHERE 1=1  AND wp_posts.post_type = 'post' AND ((wp_posts.post_status = 'publish'))
					 
					 ORDER BY RAND()
					 LIMIT 0, 3
    [posts] => Array
        (
            [0] => WP_Post Object
                (
                    [ID] => 5065
                    [post_author] => 4
                    [post_date] => 2026-09-01 14:03:32
                    [post_date_gmt] => 2026-09-01 18:03:32
                    [post_content] => 

Applications are now open for the 12th BioREACH Award Program from the Center for Biotechnology, which provides $50,000 in translational research funding for Stony Brook faculty and postdoctoral researchers to generate the evidence needed to advance promising innovations to the next stage of development.

BioREACH funds milestone-driven studies and welcomes biomedical innovations as well as platforms, tools, computational technologies, and other enabling technologies with the potential to contribute to solutions addressing unmet needs in health.

Application deadline: October 29, 2026, 5:00pm ET

For info sessions, eligibility and deadlines visit our REACH Website and FAQ.

The Center for Biotechnology (CfB) has helped advance some of Stony Brook University’s most impactful biomedical innovations, among them the yeast two-hybrid system, Xiaflex®, ReoPro®, Oracea®, and 3D virtual colonoscopy. The CfB has supported more than 475 faculty-led translational research projects and contributed to 306 license agreements generating $51 million in royalty returns to the University.

Questions? Reach out to our program contacts or sign up for office hours:

Dee Dao, PhD, Associate Director, dee.dao@stonybrook.edu
Office Hours: Monday–Friday, 2–3:30 PM | Sign up Here

Zelda Mendelowitz, PhD, Venture Associate, zelda.mendelowitz@stonybrook.edu
Office Hours: Tuesday, Wednesday, Friday, 8–11 AM | Sign up Here

[post_title] => BioREACH: Translational Research Funding Opportunity [post_excerpt] => [post_status] => publish [comment_status] => open [ping_status] => open [post_password] => [post_name] => bioreach-translational-research-funding-opportunity [to_ping] => [pinged] => [post_modified] => 2026-09-04 11:55:36 [post_modified_gmt] => 2026-09-04 15:55:36 [post_content_filtered] => [post_parent] => 0 [guid] => https://centerforbiotechnology.org/?p=5065 [menu_order] => 0 [post_type] => post [post_mime_type] => [comment_count] => 0 [filter] => raw ) [1] => WP_Post Object ( [ID] => 3214 [post_author] => 3 [post_date] => 2019-03-22 15:00:07 [post_date_gmt] => 2019-03-22 15:00:07 [post_content] => The Center for Biotechnology (CFB) announces a Request for Proposals under its Applied Research and Development Program (ARaD). Through this program, the CFB provides matching grants for Stony Brook University affiliated faculty and industry partners to collaborate on applied research and R&D projects. Projects will be evaluated based upon their potential to positively impact the corporate partner, the potential for economic impact in NYS, and the scientific and commercial merit of the proposal. The maximum award from the Center for Biotechnology will be $40K and will require a minimum 1:1 financial match from the corporate partner. Smaller projects are also encouraged. All awards, including the funding provided by the corporate partner, will be established on campus in the name of the faculty collaborator and will be governed by a corporate-sponsored research or testing agreement, depending upon the circumstances. Projects are expected to start on or about July 1. The application guidelines and forms can be found here. Deadline for submission is April 15, 2019, 5 pm. Please contact the team at the Center for Biotechnology with any questions (Project Questions: william.hanes@stonybrook.edu; Budget Questions: annette.depietri@stonybrook.edu) [post_title] => Funding Opportunity: Faculty/Industry Collaborations [post_excerpt] => Announcing a Request for Proposals under our Applied Research and Development Program (ARaD) which provides matching grants for Stony Brook University affiliated faculty and industry partners to collaborate on applied research and R&D projects. [post_status] => publish [comment_status] => open [ping_status] => open [post_password] => [post_name] => arad2019 [to_ping] => [pinged] => [post_modified] => 2019-03-22 15:01:10 [post_modified_gmt] => 2019-03-22 15:01:10 [post_content_filtered] => [post_parent] => 0 [guid] => https://centerforbiotechnology.org/?p=3214 [menu_order] => 99 [post_type] => post [post_mime_type] => [comment_count] => 0 [filter] => raw ) [2] => WP_Post Object ( [ID] => 2454 [post_author] => 4 [post_date] => 2016-11-15 21:24:24 [post_date_gmt] => 2016-11-15 21:24:24 [post_content] => The i6 Challenge award sets aim on enhancing Long Island Bioscience Ecosystem The Center for Biotechnology at Stony Brook University has announced that is has received a three-year, $500,000 U.S. Department of Commerce i6 Challenge Investment. The award will support the Center for Biotechnology’s (CFB) efforts to bolster the regional bioscience ecosystem by supporting a formal mentorship program, as well as a critical NIH-focused SBIR/STTR training and application development program which will assist in capital formation and launching new companies. The Center for Biotechnology is among 35 organizations — including nonprofits, institutions of higher education, and entrepreneurship-focused organizations — from 19 states that will receive nearly $15 million to create and expand cluster-focused, proof-of-concept and commercialization programs, and early-stage seed capital funds through the Economic Development Administration’s (EDA) Regional Innovation Strategies (RIS) program. The Office of Innovation and Entrepreneurship (OIE), housed within the U.S. Department of Commerce’s Economic Development Administration (EDA), leads the Regional Innovation Strategies Program to spur innovation capacity-building activities in regions across the nation. “Long Island’s innovation economy is rooted in cutting-edge basic and applied science and engineering, fostered by top-tier research institutions, a highly educated population, and a depth, breadth and scope of intellectual capital.” said Dr. Clinton T. Rubin, Director, Center for Biotechnology. Dr. Rubin continued, “This award and the initiatives it will support add to the growing, concentrated efforts the Center for Biotechnology, the Long Island Bioscience Hub and the hub’s partner institutions are making to grow the high technology innovations born in our region into fully realized ventures.” The Center for Biotechnology (CFB) at Stony Brook University is an Empire State Development Division of Science, Technology and Innovation (NYSTAR) Center for Advanced Technology. Established in 1983, the CFB’s efforts are focused on accelerating the development of biomedical technologies in order to have a positive impact on human health and society. The CFB is also the lead administrative institution for the Long Island Bioscience Hub (LIBH) an NIH-designated Research Evaluation and Commercialization Hub (REACH) established with a National Institutes of Health grant in 2015. The initiatives under the i6 Challenge award will complement the efforts of the LIBH, a partnership between the Center for Biotechnology, Stony Brook University, Cold Spring Harbor Laboratory, Brookhaven National Laboratory and the Feinstein Institute for Medical Research, to commercialize biomedical innovations emerging from the partner institutions. Download a PDF of the press release here. Related Articles: Schumer: Biz-Development Funds Big Deal For SBU - Innovate Long Island Stony Brook Biotech Center Wins $500,000 to Foster Companies - Newsday [post_title] => Center For Biotechnology Awarded $500k U.S. Department of Commerce Grant [post_excerpt] => The Center for Biotechnology has received a three-year, $500,000 U.S. Department of Commerce i6 Challenge Investment to support efforts to bolster the regional bioscience ecosystem. [post_status] => publish [comment_status] => open [ping_status] => open [post_password] => [post_name] => center-for-biotechnology-awarded-500k-u-s-department-of-commerce-grant [to_ping] => [pinged] => [post_modified] => 2017-03-15 13:47:39 [post_modified_gmt] => 2017-03-15 13:47:39 [post_content_filtered] => [post_parent] => 0 [guid] => http://centerforbiotechnology.org/?p=2454 [menu_order] => 158 [post_type] => post [post_mime_type] => [comment_count] => 0 [filter] => raw ) [3] => WP_Post Object ( [ID] => 2210 [post_author] => 3 [post_date] => 2016-05-12 19:03:22 [post_date_gmt] => 2016-05-12 19:03:22 [post_content] => TheraSource LLC, a Feinstein Institute for Medical Research spin-out, has received a $3 million three-year Small Business Innovation Research (SBIR) grant from the National Institute of Allergy and Infectious Diseases (NIAID), which is part of the National Institutes of Health (NIH). The grant will support the development of human ghrelin as an innovative treatment to alleviate health damage caused by unintentional radiation exposure. TheraSource has been a client of the Center for Biotechnology and the organization is proud to have played an integral role in the helping the company advance their business and technology strategy. As noted by Diane Fabel, Director of Operations for the Center for Biotechnology, “The Phase II award for TheraSource is a significant landmark for the company and an important milestone for the region.” Ping Wang, MD, founder of TheraSource and Chief of Scientific Officer (CSO) of the Feinstein Institute has stated “Human ghrelin has been investigated in clinical trials of other indications.  With our new findings, we will soon be able to file an Investigational New Drug application to US Food and Drug Administration,” said Dr. Wang. “TheraSource has received investments to fund its various projects and is seeking strategic partnerships towards the goal of clinical development and commercialization.” For more details, read the company’s press release here. [post_title] => TheraSource LLC receives $3M SBIR Grant [post_excerpt] => TheraSource LLC, a Feinstein Institute for Medical Research spin-out, has received a $3 million three-year Small Business Innovation Research (SBIR) grant from the National Institute of Allergy and Infectious Diseases (NIAID), which is part of the National Institutes of Health (NIH). [post_status] => publish [comment_status] => open [ping_status] => open [post_password] => [post_name] => therasource-llc-receives-3m-sbir-grant [to_ping] => [pinged] => [post_modified] => 2016-05-12 19:13:45 [post_modified_gmt] => 2016-05-12 19:13:45 [post_content_filtered] => [post_parent] => 0 [guid] => http://centerforbiotechnology.org/?p=2210 [menu_order] => 181 [post_type] => post [post_mime_type] => [comment_count] => 0 [filter] => raw ) ) [post_count] => 4 [current_post] => -1 [before_loop] => 1 [in_the_loop] => [post] => WP_Post Object ( [ID] => 5065 [post_author] => 4 [post_date] => 2026-09-01 14:03:32 [post_date_gmt] => 2026-09-01 18:03:32 [post_content] =>

Applications are now open for the 12th BioREACH Award Program from the Center for Biotechnology, which provides $50,000 in translational research funding for Stony Brook faculty and postdoctoral researchers to generate the evidence needed to advance promising innovations to the next stage of development.

BioREACH funds milestone-driven studies and welcomes biomedical innovations as well as platforms, tools, computational technologies, and other enabling technologies with the potential to contribute to solutions addressing unmet needs in health.

Application deadline: October 29, 2026, 5:00pm ET

For info sessions, eligibility and deadlines visit our REACH Website and FAQ.

The Center for Biotechnology (CfB) has helped advance some of Stony Brook University’s most impactful biomedical innovations, among them the yeast two-hybrid system, Xiaflex®, ReoPro®, Oracea®, and 3D virtual colonoscopy. The CfB has supported more than 475 faculty-led translational research projects and contributed to 306 license agreements generating $51 million in royalty returns to the University.

Questions? Reach out to our program contacts or sign up for office hours:

Dee Dao, PhD, Associate Director, dee.dao@stonybrook.edu
Office Hours: Monday–Friday, 2–3:30 PM | Sign up Here

Zelda Mendelowitz, PhD, Venture Associate, zelda.mendelowitz@stonybrook.edu
Office Hours: Tuesday, Wednesday, Friday, 8–11 AM | Sign up Here

[post_title] => BioREACH: Translational Research Funding Opportunity [post_excerpt] => [post_status] => publish [comment_status] => open [ping_status] => open [post_password] => [post_name] => bioreach-translational-research-funding-opportunity [to_ping] => [pinged] => [post_modified] => 2026-09-04 11:55:36 [post_modified_gmt] => 2026-09-04 15:55:36 [post_content_filtered] => [post_parent] => 0 [guid] => https://centerforbiotechnology.org/?p=5065 [menu_order] => 0 [post_type] => post [post_mime_type] => [comment_count] => 0 [filter] => raw ) [comment_count] => 0 [current_comment] => -1 [found_posts] => 286 [max_num_pages] => 96 [max_num_comment_pages] => 0 [is_single] => [is_preview] => [is_page] => [is_archive] => [is_date] => [is_year] => [is_month] => [is_day] => [is_time] => [is_author] => [is_category] => [is_tag] => [is_tax] => [is_search] => [is_feed] => [is_comment_feed] => [is_trackback] => [is_home] => 1 [is_privacy_policy] => [is_404] => [is_embed] => [is_paged] => [is_admin] => [is_attachment] => [is_singular] => [is_robots] => [is_favicon] => [is_posts_page] => [is_post_type_archive] => [query_vars_hash:WP_Query:private] => 325c4f9f1aebaa5ec90666fa54175ba0 [query_vars_changed:WP_Query:private] => [thumbnails_cached] => [allow_query_attachment_by_filename:protected] => [stopwords:WP_Query:private] => [compat_fields:WP_Query:private] => Array ( [0] => query_vars_hash [1] => query_vars_changed ) [compat_methods:WP_Query:private] => Array ( [0] => init_query_flags [1] => parse_tax_query ) [query_cache_key:WP_Query:private] => )

BioREACH: Translational Research Funding Opportunity

More Information

Funding Opportunity: Faculty/Industry Collaborations

More Information

Center For Biotechnology Awarded $500k U.S. Department of Commerce Grant

More Information

TheraSource LLC receives $3M SBIR Grant

More Information